Iovance Biotherapeutics, Inc. (IOVA) insider trading.
In Q3 2026, insiders at Iovance Biotherapeutics, Inc. reported 16 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 16
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-10
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Puri Raj K. | Officer · Chief Regulatory Officer | 4 | 0 | 0 |
| Bilinsky Igor | Officer · Chief Operating Officer | 4 | 0 | 0 |
| Vogt Frederick G | Director, Officer · Interim CEO & General Counsel | 4 | 0 | 0 |
| Kirby Daniel Gordon | Officer · Chief Commercial Officer | 2 | 0 | 0 |
| Roche Corleen M. | Officer · Chief Financial Officer | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Puri Raj K. | F (D) | 4,478 | $8.7 | 256,364 | Form 4 |
| 2026-09-08 | Puri Raj K. | M (A) | 9,766 | $0 | 260,842 | Form 4 |
| 2026-09-08 | Bilinsky Igor | M (A) | 7,813 | $0 | 146,050 | Form 4 |
| 2026-09-08 | Bilinsky Igor | F (D) | 3,976 | $8.7 | 142,074 | Form 4 |
| 2026-09-08 | Vogt Frederick G | M (A) | 15,626 | $0 | 602,085 | Form 4 |
| 2026-09-08 | Vogt Frederick G | F (D) | 6,638 | $8.7 | 595,447 | Form 4 |
| 2026-09-01 | Bilinsky Igor | M (A) | 8,789 | $0 | 142,709 | Form 4 |
| 2026-09-01 | Bilinsky Igor | F (D) | 4,472 | $8.28 | 138,237 | Form 4 |
| 2026-09-01 | Puri Raj K. | M (A) | 5,470 | $0 | 253,584 | Form 4 |
| 2026-09-01 | Puri Raj K. | F (D) | 2,508 | $8.28 | 251,076 | Form 4 |
| 2026-09-01 | Vogt Frederick G | M (A) | 41,669 | $0 | 604,161 | Form 4 |
| 2026-09-01 | Vogt Frederick G | F (D) | 17,702 | $8.28 | 586,459 | Form 4 |
| 2026-08-10 | Kirby Daniel Gordon | M (A) | 10,001 | $0 | 156,947 | Form 4 |
| 2026-08-10 | Kirby Daniel Gordon | F (D) | 2,436 | $6.4 | 154,511 | Form 4 |
| 2026-08-06 | Roche Corleen M. | F (D) | 21,238 | $6.21 | 28,757 | Form 4 |
| 2026-08-06 | Roche Corleen M. | M (A) | 49,995 | $0 | 49,995 | Form 4 |
Transaction codes in this quarter
Get IOVA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1425205&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · IOVA company page · Iovance Biotherapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Iovance Biotherapeutics, Inc. (IOVA)?
In Q3 2026, insiders at Iovance Biotherapeutics, Inc. reported 16 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Iovance Biotherapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/iova.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.